|
Name
|
Size
|
Creator |
Creation Date
|
Labels |
|
|
Microsoft Word Document
2022-01-07_SDTM_NSCLC-SAQ_V1.0_Approved_with_FDA_Comments.docx
|
73 kB |
Steve Kopko |
Feb 16, 2023 10:17 |
|
|
|
Version 1 (current)
|
73 kB |
Steve Kopko |
Feb 16, 2023 10:17 |
|
|
|
Microsoft Word Document
FDA_Response_CDISC_3rd_FDA_Review_Request_NSCLC-SAQ V1.0_2022017.docx
|
23 kB |
Steve Kopko |
Feb 16, 2023 10:17 |
|
|
|
Version 1 (current)
|
23 kB |
Steve Kopko |
Feb 16, 2023 10:17 |
|
|
|
PDF File
QRS EMAIL-CDISC QRS 3rd Review Request NSCLC-SAQ V1.0 2022-07-07.pdf
|
650 kB |
Steve Kopko |
Jan 07, 2022 15:37 |
|
|
|
Version 1 (current)
|
650 kB |
Steve Kopko |
Jan 07, 2022 15:37 |
|
|
|
PDF File
NSCLC-SAQ V1.0 Annotated CRF.pdf
|
1.21 MB |
Steve Kopko |
Jan 07, 2022 15:09 |
|
|
|
Version 1 (current)
|
1.21 MB |
Steve Kopko |
Jan 07, 2022 15:09 |
|
|
|
PDF File
NSCLC_UserManual.pdf
|
528 kB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
Version 1 (current)
|
528 kB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
PDF File
NSCLC-SAQ V1.0 ref article.pdf
|
1.19 MB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
Version 1 (current)
|
1.19 MB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
Microsoft Word Document
SDTM QS-NSCLC-SAQ V1.0 Approved 2022-01-06.docx
|
59 kB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
Version 1 (current)
|
59 kB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
Microsoft Word Document
CDISC QRS 3rd Review Request NSCLC-SAQ V1.0 2022-07-07.docx
|
22 kB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
Version 1 (current)
|
22 kB |
Steve Kopko |
Jan 07, 2022 15:04 |
|
|
|
PDF File
QRS EMAIL-CDISC QRS 2nd Review Request NSCLC-SAQ V1.0 2021-02-12.pdf
|
886 kB |
Steve Kopko |
Dec 29, 2021 14:32 |
|
|
|
Version 1 (current)
|
886 kB |
Steve Kopko |
Dec 29, 2021 14:32 |
|
|
|
Microsoft Word Document
CDISC QRS Review Request NSCLC-SAQ V1.0 2021-02-12.docx
|
22 kB |
Steve Kopko |
Feb 19, 2021 14:55 |
|
|
|
Version 2 (current)
|
22 kB |
Steve Kopko |
Feb 19, 2021 14:55 |
|
|
|
Version 1
|
22 kB |
Steve Kopko |
Feb 12, 2021 13:10 |
|
|
|
Microsoft Excel Spreadsheet
FDA NSCLC-SAQ V1.0 JIRA Issues Export View - Issue Tracker JIRA 2021-02-12.xlsx
|
21 kB |
Steve Kopko |
Feb 12, 2021 13:13 |
|
|
|
Version 1 (current)
|
21 kB |
Steve Kopko |
Feb 12, 2021 13:13 |
|
|
|
Microsoft Word Document
SDTM QS-NSCLC-SAQ V1 Approved 2021-01-25.docx
|
60 kB |
Steve Kopko |
Feb 12, 2021 13:12 |
|
|
|
Version 1 (current)
|
60 kB |
Steve Kopko |
Feb 12, 2021 13:12 |
|
|
|
Microsoft Word Document
SDTM QS NSCLC-SAQ V1.0 Approved__FDA Comments 2020-06-03 .docx
|
67 kB |
Steve Kopko |
Feb 12, 2021 12:55 |
|
|
|
Version 1 (current)
|
67 kB |
Steve Kopko |
Feb 12, 2021 12:55 |
|
|
|
PDF File
QRS EMAIL FDA Comments on NSCLC and SMDDS CConley 2020-06-03.pdf
|
556 kB |
Steve Kopko |
Feb 12, 2021 12:52 |
|
|
|
Version 1 (current)
|
556 kB |
Steve Kopko |
Feb 12, 2021 12:52 |
|
|